BUVEL v. BRISTOL MYERS SQUIBB CO.

District Court, D. New Jersey·Decided August 15, 2024·No. 3:22-cv-06449·Unknown

Opinion

NOT FOR PUBLICATION UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

LYNDA BUVEL, et ai., Plaintiffs, Civil Action No. 22-6449 (ZNQ) (IBD) v. OPINION BRISTOL MYERS SQUIBB CO., Defendant. QURAISHL District Judge THIS MATTER comes before the Court upon the Motion to Partially Dismiss Plaintiff Srilatha Kuntumaila’s First Amended Complaint (the “Motion,” ECF No, 25) filed by Defendant Bristol Myers Squibb Company (“BMS” or “Defendant”). Defendant filed a brief in support of the Motion (“Moving Br.,” ECF No, 25-1). Plaintiff Srilatha Kuntumalla (“Plaintiff’ or “Plaintiff Kuntumalla”) filed an opposition brief (““Opp’n Br.,” ECF No. 30), to which Defendant replied (“Reply Br.,” ECF No. 32). After careful consideration of the parties’ submissions, the Court decides the Motion without oral argument pursuant to Federal Rule of Civil Procedure 78 and Local Civil Rule 78.1.1 For the reasons outlined below, the Court will GRANT Defendant’s Motion to Dismiss Plaintiff Kuntumalla’s claims. I. BACKGROUND AND PROCEDURAL HISTORY? The First Amended Complaint (the “Amended Complaint”) asserts claims on behalf of BMS employees who were terminated for refusing to be vaccinated for COVID-19. As a

' Hereinafter, all references to “Rule” or “Rules” refer to the Federal Rules of Civil Procedure. For the purpose of considering the instant Motion, the Court accepts all factual allegations in the Complaint as true. See Phillips v. County of Allegheny, 515 F.3d 224, 233 (3d Cir. 2008).

preliminary matter, the Court notes that while this Motion only addresses Plaintiff Kuntumalla’s claims, the Amended Complaint (ECF No. 3) was actually filed on behalf of six named plaintiffs and “all similarly situated individuals,” although no proposed class was defined. The Amended Complaint complicates the Court’s review because it attempts to collectively plead certain facts with respect to all of the plaintiffs, making it difficult to consider the allegations supporting Plaintiff Kuntumalla’s claims,? At all times relevant to this action, Plaintiff Kuntumalla worked for BMS, a global drug manufacturer. (Am. Compl. fff 16, 25.) During her tenure with the company, Plaintiff was productive and promoted by the BMS. (Ud. ¥ 58.) All of the named plaintiffs were “very high level employees” with years of experience and education. (/d. J 30.) On or about September 7, 2021, Defendant created a policy which required its U.S. employees to be fully vaccinated against COVID-19 by November 1, 2021.4 Ud. 42-43.) Defendant told its employees to either request an exemption, comply with the requirement, or lose their jobs. Ud. 44-45, 49.) Defendant publicly represented that it would accept two types of exemption requests—imedical and religious. (Ud. | 28.) However, Defendant failed to follow its exemption policy by arbitrarily denying requests that it received and failing to establish an appeal process for denied accommodations.’ (Jd. | 45-46, 53.) The named plaintiffs each requested a “medical and /or religious exemption” from the vaccine requirement. (/d. 29.) They expressed concern to Defendant about the general safety

3 For instance, the Amended Complaint alleges that “[eJach of these Plaintiff's [sic] maintained a medical and/or religious exemption that was ignored by BMS,” leaving it unclear as to whether Plaintiff Kuntumalla sought a medical! or religious exemption or both from BMS. * Initially, BMS allowed its employees “several days and weeks of exemption” from the yaccination requirement, permitting them to work remotely “100% of the time” regardless of their religious beliefs. (Am. Compl. Jf 3-5.) However, at some later point in time BMS suspended the work-from-home accommodations, and terminated its employees if they did not receive the COVID-19 vaccine. (Ud J 5.) ° Defendant did have an independent site through which internal claims of discrimination were filed, but “many of the claims were denied without investigation within 24 business hours.” (/d. 147.)

and efficacy of the vaccine, (/d. | 30.) They also raised the vaccine’s potential association with pulmonary immunopathology and its lack of standard approval by the Food and Drug Administration. Ud 37, 39, 51, 54.) “Some [p]laintiffs were fired for failure to take a shot which would create a conflict with their sincerely held beliefs due to the use of fetal cells in the shot. Others were fired despite medical concerns with taking the shot.” 977.) Plaintiffs informed BMS that their religious beliefs conflicted with the COVID-19 vaccine. Ud. § 75.) Ultimately, BMS terminated all of the named plaintiffs for refusing to be vaccinated. Ud. J 50.) Plaintiff Kuntumatla was terminated on December 6, 2021.° Ud. 4 16, 51.) Plaintiff filed a charge (“Charge”) for retaliation and religious discrimination with the Equal Employment Opportunity Commission (“EEOC”). Ud. 94 11, 16.) On August 4, 2022, Plaintiff received her Right to Sue letter from the EEOC. (id. 4 16.) On November 3, 2022, Plaintiff Kuntumalla, along with the other named plaintiffs, filed this lawsuit. (ECF No. 1.) The other plaintiffs subsequently stipulated with BMS to arbitrate their claims. (See ECF Nos. 37, 45.) The Motion challenges Plaintiff's assault and battery claim (Count One), religious discrimination claims (Counts Two and Five, which bring failure to accommodate theories, and Counts Three and Five,’ which bring wrongful termination theories), and claim for declaratory judgment (Count Six). Ik. JURISDICTION The Court has subject matter jurisdiction over the claims herein pursuant to 28 U.S.C. §§ 1331, 1332, and 1367.

® The Amended Complaint adds that Plaintiff was performing her job satisfactorily at the time of her termination. (Id Court notes that Count Five raises religious discrimination under the New Jersey Law Against Discrimination (NJLAD”) with both failure to accommodate and wrongful termination theories. (See id. Ff] 97-109.)

Free access — add to your briefcase to read the full text and ask questions with AI

BUVEL v. BRISTOL MYERS SQUIBB CO., (D.N.J. 2024).

BUVEL v. BRISTOL MYERS SQUIBB CO. (BUVEL v. BRISTOL MYERS SQUIBB CO.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Karen Malleus v. John George
641 F.3d 560 (Third Circuit, 2011)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Wigginton v. Servidio
734 A.2d 798 (New Jersey Superior Court App Division, 1999)
Kelly v. County of Monmouth
883 A.2d 411 (New Jersey Superior Court App Division, 2005)
Leang v. Jersey City Board of Education
969 A.2d 1097 (Supreme Court of New Jersey, 2009)
Tribune Media Company v.
902 F.3d 384 (Third Circuit, 2018)
Ewing v. Cumberland County
152 F. Supp. 3d 269 (D. New Jersey, 2015)
Kehr Packages, Inc. v. Fidelcor, Inc.
926 F.2d 1406 (Third Circuit, 1991)